| Financial Year |
March 31 2023 |
| Monetary Funds |
2,570,313,892.58 |
| Held-for-trading Financial Assets |
752,935,251.14 |
| Notes Receivable |
3,000,000.00 |
| Accounts Receivable |
2,428,169,644.16 |
| Advances to Suppliers |
30,869,647.55 |
| Other Receivables |
79,886,908.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,059,384.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
284,514,724.89 |
| Total Current Assets |
6,409,842,714.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
209,770,476.15 |
| Investment Properties |
-- |
| Fixed Assetes |
6,275,454,873.44 |
| Under-construction Projects |
1,651,277,781.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,709,710,966.91 |
| R&D expenses |
-- |
| Goodwill |
1,877,160.08 |
| Long-Term Deferred and Prepaid Expenses |
26,050,074.77 |
| Deferred Income Tax Assets |
86,548,311.05 |
| Other Non-Current Assets |
333,158,398.96 |
| Sub-Total of Non-Current Assets |
13,313,228,875.01 |
| Total Assets |
19,723,071,589.40 |
| Short-Term Loans |
830,629,791.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
258,447,178.33 |
| Accounts Payable |
1,401,109,114.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,951,420.08 |
| Taxes Payable |
89,003,847.40 |
| Interest Payable |
-- |
| Dividend Payable |
4,723,300.00 |
| Other payables |
81,601,059.37 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
745,134,196.26 |
| Other Current Liabilities |
276,752,414.90 |
| Sub-Total of Current Liabilities |
3,774,031,628.22 |
| Long-term Loans |
6,415,946,010.00 |
| Bonds Payable |
314,791,666.66 |
| Long-Term Accounts Payable |
4,529,285.27 |
| Special Payable |
-- |
| Estimatied Liabilities |
15,057,716.88 |
| Deferred Income Tax Liabilities |
176,542.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,806,099,345.47 |
| Total Liabilities |
10,580,130,973.69 |
| Paid-In Capital(Or Share Stock) |
1,475,926,818.00 |
| Capital Surplus |
3,774,900,129.66 |
| Surplus Reserve |
200,983,680.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
186,592,114.71 |
| Minority Stockholder's Interest |
3,498,382,014.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,644,558,601.32 |
| Owner's Equity（Stockholder's Equity） |
9,142,940,615.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,723,071,589.40 |
